Adage Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.2M | Buy |
|
|||||
|
2025
Q2 | $9.07M | Sell |
|
|||||
|
2025
Q1 | $119M | Sell |
|
|||||
|
2024
Q4 | $439M | Buy |
|
|||||
|
2024
Q3 | $233M | Buy |
|
|||||
|
2024
Q2 | $36.2M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $9.3M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $28.6M | Sell |
|
|||||
|
2022
Q4 | $61.4M | Sell |
|
|||||
|
2022
Q3 | $158M | Buy |
|
|||||
|
2022
Q2 | $76.8M | Buy |
|
|||||
|
2022
Q1 | $41.4M | Buy |
|
|||||
|
2021
Q4 | $31.4M | Sell |
|
|||||
|
2021
Q3 | $48.1M | Sell |
|
|||||
|
2021
Q2 | $91.7M | Sell |
|
|||||
|
2021
Q1 | $90.9M | Sell |
|
|||||
|
2020
Q4 | $117M | Sell |
|
|||||
|
2020
Q3 | $134M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $122M | Sell |
|
|||||
|
2019
Q4 | $142M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $40.6M | Sell |
|
|||||
|
2018
Q4 | $92.8M | Buy |
|
|||||
|
2018
Q3 | $109M | Buy |
|
|||||
|
2018
Q2 | $90.6M | Sell |
|
|||||
|
2018
Q1 | $173M | Buy |
|
|||||
|
2017
Q4 | $143M | Buy |
|
|||||
|
2017
Q3 | $119M | Sell |
|
|||||
|
2017
Q2 | $113M | Buy |
|
|||||
|
2017
Q1 | $77.1M | Sell |
|
|||||
|
2016
Q4 | $153M | Buy |
|
|||||
|
2016
Q3 | $131M | Sell |
|
|||||
|
2016
Q2 | $397M | Sell |
|
|||||
|
2016
Q1 | $365M | Buy |
|
|||||
|
2015
Q4 | $386M | Buy |
|
|||||
|
2015
Q3 | $264M | Sell |
|
|||||
|
2015
Q2 | $338M | Sell |
|
|||||
|
2015
Q1 | $455M | Buy |
|
|||||
|
2014
Q4 | $282M | Buy |
|
|||||
|
2014
Q3 | $236M | Sell |
|
|||||
|
2014
Q2 | $240M | Sell |
|
|||||
|
2014
Q1 | $374M | Sell |
|
|||||
|
2013
Q4 | $466M | Buy |
|
|||||
|
2013
Q3 | $364M | Sell |
|
|||||
|
2013
Q2 | $448M | Buy |
|